PEMFEXY

Serial Number 87365305
606

Registration Progress

Application Filed
Mar 9, 2017
Under Examination
Oct 10, 2017
Approved for Publication
Aug 15, 2017
Published for Opposition
Aug 15, 2017
Registered

Trademark Image

PEMFEXY

Basic Information

Serial Number
87365305
Filing Date
March 9, 2017
Published for Opposition
August 15, 2017
Abandonment Date
November 16, 2020
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 16, 2020
Classes
005

Rights Holder

Eagle Pharmaceuticals Inc.

03
Address
50 Tice Boulevard, Suite 315
Woodcliff Lake, NJ 07677

Ownership History

Eagle Pharmaceuticals Inc.

Original Applicant
03
Woodcliff Lake, NJ

Eagle Pharmaceuticals Inc.

Owner at Publication
03
Woodcliff Lake, NJ

Legal Representation

Attorney
Jacqueline M. Lesser

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

36 events
Date Code Type Description Documents
Nov 16, 2020 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Nov 16, 2020 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 15, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 14, 2020 EX5G S SOU EXTENSION 5 GRANTED Loading...
Apr 14, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 10, 2020 EXT5 S SOU EXTENSION 5 FILED Loading...
Apr 10, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 3, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 30, 2019 EX4G S SOU EXTENSION 4 GRANTED Loading...
Aug 30, 2019 EXT4 S SOU EXTENSION 4 FILED Loading...
Aug 30, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 23, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 21, 2019 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 21, 2019 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 21, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 29, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 27, 2018 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 27, 2018 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 27, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 31, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 29, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 29, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 29, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 10, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 15, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 15, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 26, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 5, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 5, 2017 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 5, 2017 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 5, 2017 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jun 5, 2017 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 2, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 16, 2017 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Mar 15, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 13, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for treatment of lung cancer

Additional Information

Design Mark
The mark consists of the term "PEMFEXY", with the letters "P" "E" "M" F" "E" and "Y" in the color teal, while the letter "X" and the tear drop that is centered over the "X" both appear in the color turquoise.
Color Claim
The colors teal and turquoise are claimed as a feature of the mark.

Classification

International Classes
005